AL-12182, a novel 11-oxa prostaglandin analog with topical ocular hypotensive activity in the monkey

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 17, 2004, Pages 4525-4528

  Selliah, Robert D ^a   Hellberg, Mark R ^a   Sharif, Najam A ^a   McLaughlin, Marsha A ^a   Williams, Gary W ^a   Scott, Daniel A ^a   Earnest, David ^a   Haggard, Karen S ^a   Dennis Dean, W ^a   Delgado, Pete ^a   Gaines, Michael S ^a   Conrow, Raymond E ^a   Klimko, Peter G ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

11 Oxa prostaglandin; Glaucoma

Indexed keywords

AL 12182; ANTIHYPERTENSIVE AGENT; LATANOPROST; PROSTAGLANDIN DERIVATIVE; SORBITOL; TRAVOPROST;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; INTRAOCULAR PRESSURE; NONHUMAN; RECEPTOR BINDING;

ADMINISTRATION, TOPICAL; ANIMALS; CATS; HAPLORHINI; OCULAR HYPOTENSION; PROSTAGLANDINS; RABBITS;

ORYCTOLAGUS CUNICULUS;

EID: 3843096238     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.06.037     Document Type: Article

References (31)

1. Clark A.F. Emerg. Drugs. 4:1999;333
2. Alm A. Curr. Opin. Ophthalmol. 4:1993;44
3. Bito L.Z. Surv. Ophthalmol. 41(Suppl. 2):1997;S1
4. Hellberg M.R., McLaughlin M.A., Sharif N.A., DeSantis L., Dean T.R., Kyba E.P., Bishop J.E., Klimko P.G., Zinke P.W., Selliah R.D., Barnes G., DeFaller J., Kothe A., Landry T., Sullivan E.K., Andrew R., Davis A.A., Silver L., Bergamini M.V.W., Robertson S., Weiner A.L., Sallee V.L. Surv. Ophthalmol. 47(Suppl. 1):2002;1
5. Hanessian S., Guindon Y., Lavallée P., Dextraze P. Carbohydr. Res. 141:1985;221
6. Thiem J., Lüders H. Liebigs Ann. Chem. 1985;2151
7. Verdoorn G.H., Holzapfel C.W., Koekemoer J.M. S.Afr. J. Chem. 40:1987;134
8. Corey, E. J.; Frederick, J. U.K. Patent Appl. GB 1,539,364 A, 1979
9. Lourens, G. J.; Koekemoer, J. M. U.S. Patent 4,133,817, 1979
10. Griffin B.W., Williams G.W., Crider J.Y., Sharif N.A. J. Pharmacol. Exp. Ther. 281:1997;845
11. Sharif N.A., Xu S.X., Williams G.W., Crider J.Y., Griffin B.W., Davis T.L. J. Pharmacol. Exp. Ther. 286:1998;1094
12. Klimko P.G., Davis T.L., Griffin B.W., Sharif N.A. J. Med. Chem. 43:2000;3400. see footnote 18 therein
13. Bowler J., Brown E.D., Crossley N.S., Heaton D.W., Lilley T.J., Rose N. Prostaglandins. 17:1979;789
14. Gréen K. Prostaglandins. 15:1978;813
15. Klimko, P. G.; Zinke, P. W. U.S. Patent 6,235,779, 2001
16. 4, 34,000; IP, >62,000; TP, 25,000
17. Delgado, P.; Conrow, R. E.; Dean, W. D.; Gaines, M. S. U.S. Patents 6,441,196, 2002; 6,620,947, 2003
18. Bock K., Pedersen C., Thøgersen H. Acta Chem. Scand. B. 35:1981;441
19. Duclos A., Fayet C., Gelas J. Synthesis. 1994;1087
20. See: Casy G., Patterson J.W., Taylor R.J. Organic Syntheses. Coll. Vol. VIII:1993;415-420 Wiley, New York
21. Xie M., Berges D.A., Robins M.J. J. Org. Chem. 61:1996;5178
22. Rathke M.W., Nowak M. J. Org. Chem. 50:1985;2624
23. Itsuno S. Organic Reactions. Vol. 52:1998;430-434 Wiley, New York
24. Imwinkelried R., Schiess M., Seebach D. Organic Syntheses. Coll. Vol. VIII:1993;201-204 Wiley, New York
25. Gras J.-L., Soto T., Viala J. Tetrahedron: Asymmetry. 10:1999;139
26. Barrett A.G.M., Hamprecht D., White A.J.P., Williams D.J. J. Am. Chem. Soc. 119:1997;8608
27. 17 by a modified method of: Caballero E., Guilhot F., López J.L., Medarde M., Sahagún H., Tomé F. Tetrahedron Lett. 37:1996;6951
28. Henegar, K. E. U.S. Patent Appl. 2003/0045571 A1
29. For a completely different synthesis of the bis TBDMS analog of 25 see: Fox, M. E.; Jackson, M. PCT Int. Appl. WO01/87897A1, 2001
30. Trost B.M., Belletire J.L., Godleski S., McDougal P.G., Balkovec J.M., Baldwin J.J., Christy M.E., Ponticello G.S., Varga S.L., Springer J.P. J. Org. Chem. 51:1986;2370
31. Latypov Sh.K., Seco J.M., Quiñoá E., Riguera R. J. Org. Chem. 61:1996;8569